Jump To Jump To Watch View Summit Archive Top 10 Things to Know About Prostate Cancer Clinical Trials March 3, 2021 Elisabeth Heath, professor of Oncology & Medicine at Karmanos Cancer Institute, and Charles Ryan, professor of Medicine at the University of Minnesota, share important things to know about prostate cancer clinical trials. Clinical trials must reflect the patient community so that new and better treatment options become available. Researchers and trial sponsors can confront health disparities by ensuring clinical trials are diverse, inclusive, and representative of the entire patient population.This session was part of our VIRTUAL ZERO Prostate Cancer Summit, a free online event that took place from February 28 to March 4, 2021.Watch Summit Session Archives At each ZERO Summit, you'll experience the Bold for Blue Awards, educational sessions, advocacy training, and more. See the video archives to find more of what you can expect to see when you join us at this year’s Summit! View Summit Archive Access to Healthcare Clinical Trials Health Equity Living with Prostate Cancer Treatment Options Videos & Webinars ZERO Prostate Cancer Summit View All Contributors Elisabeth Heath, MD, FACP, Patricia C. and E. Jan Hartmann endowed chair in prostate cancer research Dr. Heath has more than 26 years of experience and is a leading patient advocate for the metro Detroit community. At the ZERO Prostate Cancer Summit, she spoke about funding clinical trials and how that translates into better care for prostate cancer patients. Learn more about Elisabeth Charles Ryan, MD, MD Professor of Medicine Charles J. Ryan, M.D., is the President and CEO of the Prostate Cancer Foundation. Dr. Ryan is an internationally recognized genitourinary (GU) oncologist with expertise in the biology and treatment of advanced disease as well as the supportive care of all men with prostate cancer. Learn more about Charles Shelby Moneer, Vice President, Patient Programs & Education Missouri native dreaming of the beaches in basically any location that isn't land-locked. Lover of exercise, sports, candy, sushi, and coffee. Fiercly loyal to my family and friends. Learn more about Shelby More for you
Elisabeth Heath, professor of Oncology & Medicine at Karmanos Cancer Institute, and Charles Ryan, professor of Medicine at the University of Minnesota, share important things to know about prostate cancer clinical trials. Clinical trials must reflect the patient community so that new and better treatment options become available. Researchers and trial sponsors can confront health disparities by ensuring clinical trials are diverse, inclusive, and representative of the entire patient population.This session was part of our VIRTUAL ZERO Prostate Cancer Summit, a free online event that took place from February 28 to March 4, 2021.Watch
Summit Session Archives At each ZERO Summit, you'll experience the Bold for Blue Awards, educational sessions, advocacy training, and more. See the video archives to find more of what you can expect to see when you join us at this year’s Summit! View Summit Archive
Access to Healthcare Clinical Trials Health Equity Living with Prostate Cancer Treatment Options Videos & Webinars ZERO Prostate Cancer Summit View All
